Range of targeted oncology medications marketed by LDS Pharma to support effective treatment and management of cervical cancer, ovarian cancer and breast cancer. The range include:
Therapeutic Redemption
Therapeutic Redemption
- Bendalab ® Injection (Bortezomib Injection 3.5 mg)
- Carbolab ® 450 mg Injection (Carboplatin 10mg/ml)
- Carbolab ® 150 mg Injection (Carboplatin 10mg/ml)
- Cisplab ® 10 mg Injection (Cisplatin 1mg/ml)
- Cisplab ® 10 mg Injection (Cisplatin 1mg/ml)
- Capecitabine ACTe ® 500mg Tablets (Capicitabine 500mg)
- Epicin ® 10 mg Injection (Epirubicin Hydrochloride 10mg)
- Epicin ® 50 mg Injection (Epirubicin Hydrochloride 50mg)
- Gemibine ® 1g Injection (Gemcitabine Hydrochloride 1g)
- Gemibine ® 200 mg Injection (Gemcitabine Hydrochloride 200mg)
- Nab-Paclid ® 100 mg Injection Paclitaxel (albumin-bound 100mg
